(Q53399392)
Statements
Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group. (English)
Ferrari MD
1 reference
Wilkinson M
Hirt D
Lataste X
Notter M
1 June 1991
45
3
283-291